NORDIC MEDICAL SOLUTIONS ApS: Financial statements 2019
CVR: 34352542
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
NORDIC MEDICAL SOLUTIONS ApS (CVR 34352542) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 34,308,675 and a net result of DKK 19,910,965 compared with DKK 18,738,763 the year before. That is an increase of 13.8% compared with the year before. Equity in the 2019 report amounted to DKK 22,910,965. The solvency ratio was 52.9%. The company had 8 employees in the financial year.
- Gross Profit
- DKK 34,308,675
- Profit/Loss
- DKK 19,910,965
- Equity
- DKK 22,910,965
- Total Assets
- DKK 43,335,345
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 34.3M | 19.9M | 22.9M | 8 |
| 2018 | - | 30.1M | 18.7M | 20.7M | 9 |
| 2017 | - | 24.6M | 15.3M | 17.3M | - |
| 2016 | - | 23.1M | 15.3M | 16.8M | - |
| 2015 | - | 17.7M | 11.3M | 12M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of September 24, 2019, Pernille Wandrup Rex has joined the board of directors of NORDIC MEDICAL SOLUTIONS ApS.
As of September 24, 2019, Pernille Wandrup Rex is registered as director of NORDIC MEDICAL SOLUTIONS ApS.
About NORDIC MEDICAL SOLUTIONS ApS
NORDIC MEDICAL SOLUTIONS ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2012. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named NORDIC PHARMA SOLUTIONS ApS. The management consists of Pernille Wandrup Rex. The board consists of Kim Erik Ginnerup (chair), Monica Reib, Pernille Wandrup Rex and Philip Fischer Stavnstrup. The company is owned by NMS Group A/S. The company has 16 employees (2026). In 2026, the company reported a gross profit of DKK 56,510,150 and a net result of DKK 31,681,814 compared with DKK 28,614,955 the year before. Equity in the 2026 report amounted to DKK 40,681,814.
